GB2144409A - Preparation of 5'-deoxy-5'-methylthioadenosine - Google Patents

Preparation of 5'-deoxy-5'-methylthioadenosine Download PDF

Info

Publication number
GB2144409A
GB2144409A GB08321947A GB8321947A GB2144409A GB 2144409 A GB2144409 A GB 2144409A GB 08321947 A GB08321947 A GB 08321947A GB 8321947 A GB8321947 A GB 8321947A GB 2144409 A GB2144409 A GB 2144409A
Authority
GB
United Kingdom
Prior art keywords
deoxy
aqueous solution
methylthioadenosine
methionine
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08321947A
Other versions
GB2144409B (en
GB8321947D0 (en
Inventor
Giorgio Stramentinoli
Federico Gennari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioresearch SRL
Original Assignee
Bioresearch SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch SRL filed Critical Bioresearch SRL
Publication of GB8321947D0 publication Critical patent/GB8321947D0/en
Publication of GB2144409A publication Critical patent/GB2144409A/en
Application granted granted Critical
Publication of GB2144409B publication Critical patent/GB2144409B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A method of preparing 5'-deoxy-5'-methylthiodenosine comprises hydrolysing a concentrated aqueous solution of S-adenosyl-methionine by heating under reflux, neutralising the reaction mixture and cooling it to separate the 5'-deoxy-5'-methylthioadenosine formed.

Description

1 GB 2 144 409 A 1
SPECIFICATION
Preparation of 5'-deoxy-S'-methyithioadenosine This invention is concerned with improvements in and relating to 5'-deoxy- 5'-methyithioadenosine. In our copending application No. 8112428 we describe and claim therapeutic compositions of antiffif lammatory, analgesic and antipyretic activity in dosage unit form and containing, from 25 to 100.2 mg of an active principle of the general formula:
HH-Rl c W H LH2--K 0 OR2 OR2 (1) in which: R is a linear or branched alkyl radical containing 1-18 C atoms or a phenylalkylene radical in which the alkylene chain contains 1-6 C atoms; R, is H, an aliphatic acyl radical containing 1-6 C atoms or an aromatic acyl radical; R2 is H; and n is 0 or 1. Of all the products prepared, the one which has proved particularly interesting is 5'-deoxy- 5'methylthioadenosine (MTA) of the formula:
NH2 0 ON ON EN2-S-EN3 (H) A method has been found for preparing this product which is particularly simple and economical from an industrial viewpoint. The new process consists essentially of carrying out hydrolysis of Sadenosyimethionine (SAME) under strictly controlled critical conditions, which lead to practically total hydrolysis and complete crystallisation of the IVITA 1H2 NH2 j 1 H20 CH -S-CH -CH - CH - COON H N 2 2 2 Y0 CH3 ON ON N 1. ' J > CH -5-CH N H 0 2 3 ON ON NH2 1 HO-Ln-Lt'2LM-LOOH+H+ GB 2 144 409 A The controlled hydrolysis process can be applied to SAME prepared in any manner.
However, the method of preparation of the SAME solution is also an influencing factor in carrying out the new process in an economically convenient manner.
The following operational stages provide the most economical embodiment of the process:
(a) Normal bread yeast is enriched in SAME by treatment with methionine in accordance with the Schienk method (Schlenk F (1975) Enzymologie 29, 283).
(b) The yeast cells suspended in water are lysed by treatment with ethyl or methyl acetate at ambient temperature (DT-OS P23 36401.4).
By adjusting the pH to between 4 and 6 and filtering, an aqueous solution is obtained containing practically ail the SAME present in the initial yeast.
(c) The solution is concentrated under vacuum at 35-40'C to about 1/10 of its initial volume.
(d) The concentrate is boiled uner reflux for about 30 minutes and the pH is adjusted to 7 with soda.
(e) The solution is left to stand at 0 - WC, and the precipitated IVITA is collected practically completely and in good purity.
The steps of c, d and e, which as stated are critically necessary for obtaining complete selective hydrolysis 15 of SAME to MTA without formation of by-products, are new.
The following example illustrates the present invention.
Example
Preparation of 5'-deoxy-5'-methylthioadenosine(MTA) 11 litres of ethyl acetate and 11 litres of water at ambient temperature are added to 90 kg of bread yeast which has been enriched in SAME by adding methionine until the SAME content is 6.88 glkg. After energetic stirring for 30 minutes, the pH is adjusted to 4.5 with dilute H2S04, the mixture is filtered and the residue is washed with waterto give 140 litres of solution with a SAME content of 4. 40 g/1, equal to 99.5% of the SAME present in the initial material.
The lysate thus obtained is concentrated under vacuum (30 mm Hq; 35-40'C) to a volume of about 14 litres.
The concentrated solution is boiled under reflux at normal pressure for 30 minutes. It is cooled to 20'C, the pH adjusted to 7 with 40% by weight soda, andleft overnight in a refrigeration cell (+3'C). A white precipitate is formed which is filtered, dissolved in 10 litres of boiling distilled water and crystallised by cooling this solution. 410 g of crystalline MTA of high purity are obtained, equal to a yield of 90% with respect to the 30 SAME subjected to hydrolysis.
The characteristics of the product obtained coincide with those of pure MTA obtained by other means.

Claims (3)

1. A process for preparing 5'-deoxy-5'-methyi-thioadenosine, wherein Sadenosyl-methionine in concentrated aqueous solution, is hydrolysed by heating under reflux, and the 5'-deoxy-5'-methyithioadenosine formed is precipitated from the aqueous solution by cooling after neutralising the reaction mixture.
2. A process as claimed in claim 1 wherein the aqueous solution of Sadenosyl-methionine is 40 concentrated by heating under vacuum to 35 40'C.
3. A process as claimed in claim 2 or claim 3, wherein the 5'-deoxy-5'methyithioadenosine formed is precipitated by cooling to O-WC.
Printed in the UK for HMSO, D8818935, 1185, 7102. Published by The Patent Office, 25 Southampton Buildings, London, WC2A lAY, from which copies may be obtained.
t
GB08321947A 1980-04-22 1983-08-15 Preparation of 5'-deoxy-5'-methylthioadenosine Expired GB2144409B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21550/80A IT1193529B (en) 1980-04-22 1980-04-22 ADENOSINIC DERIVATIVES FOR ANTI-INFLAMMATORY AND ANALGESIC ACTIVITIES AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM AS AN ACTIVE PRINCIPLE

Publications (3)

Publication Number Publication Date
GB8321947D0 GB8321947D0 (en) 1983-09-14
GB2144409A true GB2144409A (en) 1985-03-06
GB2144409B GB2144409B (en) 1985-09-11

Family

ID=11183457

Family Applications (3)

Application Number Title Priority Date Filing Date
GB8112428A Expired GB2074446B (en) 1980-04-22 1981-04-22 Adenosine derivatives of antiinflammatory and analgesic activity and therapeutic compositions containing them
GB08321947A Expired GB2144409B (en) 1980-04-22 1983-08-15 Preparation of 5'-deoxy-5'-methylthioadenosine
GB08413454A Expired GB2144038B (en) 1980-04-22 1984-05-25 Adenosine derivatives of anti-inflammatory and analgesic activity and therapeutic compositions containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB8112428A Expired GB2074446B (en) 1980-04-22 1981-04-22 Adenosine derivatives of antiinflammatory and analgesic activity and therapeutic compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB08413454A Expired GB2144038B (en) 1980-04-22 1984-05-25 Adenosine derivatives of anti-inflammatory and analgesic activity and therapeutic compositions containing them

Country Status (17)

Country Link
JP (2) JPS56166117A (en)
AR (1) AR231144A1 (en)
BE (1) BE888472A (en)
CA (1) CA1198105A (en)
CH (2) CH650514A5 (en)
DE (1) DE3116067A1 (en)
DK (1) DK159453C (en)
ES (2) ES8206551A1 (en)
FI (1) FI70227C (en)
FR (1) FR2491761A1 (en)
GB (3) GB2074446B (en)
IT (1) IT1193529B (en)
LU (1) LU83307A1 (en)
MX (1) MX9203630A (en)
NL (1) NL192111C (en)
NO (1) NO150515C (en)
SE (3) SE460198B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177373B (en) * 1984-12-06 1987-08-26 Bioresearch Spa SALTS OF 5'-METHYLLIUM-5'-DEOXYDENOSINE WITH LONG ALCHYLIC CHAIN SULPHONIC ACIDS
IT1227049B (en) * 1988-07-29 1991-03-14 Bioresearch Spa USE OF ADENOSINIC DERIVATIVES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING IMMUNOSTIMULATING ACTIVITIES.
JPH0497287A (en) * 1990-08-10 1992-03-30 Nec Ic Microcomput Syst Ltd Picture display integrated circuit
ES2334924T3 (en) * 2005-03-17 2010-03-17 Proyecto De Biomedicina Cima, S.L. EMPLOYMENT OF 5'-METHYLTIOADENOSINE (MTA) IN THE PREVENTION AND / OR TREATMENT OF AUTOIMMUNE DISEASES AND / OR REJECTION OF TRANSPLANTS.
ES2259552B1 (en) * 2005-03-17 2007-06-16 Proyecto De Biomedicina Cima, S.L. EMPLOYMENT OF 5'-METHYLTIOENENINE (MTA) IN THE PREVENTION AND / OR TREATMENT OF AUTOIMMUNE DISEASES AND / OR REPLACEMENT OF TRANSPLANTS.
DE102010027595A1 (en) * 2010-07-23 2012-01-26 Helmut Vorbrüggen Clinical application of adenosine derivative, preferably (dihydroxyphenyl)ethyl-amino-purin-9-yl-(hydroxymethyl)oxolane-diol, for reducing body temperature during impending ischemia of brain vessels, which occur during heart attacks
DE102011005232A1 (en) * 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosine and its derivatives for use in pain therapy
JP6214628B2 (en) * 2013-04-05 2017-10-18 ライオン株式会社 Oral composition
WO2014163152A1 (en) * 2013-04-05 2014-10-09 ライオン株式会社 Non-rem sleep-promoting agent, deep sleep-promoting agent and natural sleep-inducing agent
WO2014163151A1 (en) * 2013-04-05 2014-10-09 ライオン株式会社 Yeast culture, and composition for internal application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1259341B (en) * 1962-12-22 1968-01-25 Boehringer & Soehne Gmbh Process for the preparation of new 5'-sulfoxides of nucleosides
DE1545645A1 (en) * 1965-12-06 1969-08-21 Boehringer Mannheim Gmbh Process for the preparation of disubstituted adenosine derivatives
FR2252405B1 (en) * 1973-11-27 1978-04-28 Ajinomoto Kk
FR2313937A1 (en) * 1975-06-09 1977-01-07 Anvar DRUG BASED ON 5 'THIOETHERS OF ADENOSINE
FR2424027A1 (en) * 1978-04-28 1979-11-23 Merieux Inst NEW MEDICINAL PRODUCT, IN PARTICULAR SEDATIVE AND SLEEP INDUCER AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Also Published As

Publication number Publication date
GB2144038B (en) 1985-08-29
GB8413454D0 (en) 1984-07-04
SE466238B (en) 1992-01-20
SE8700913L (en) 1987-03-04
DK176481A (en) 1981-10-23
NO150515C (en) 1984-10-31
JPH01301692A (en) 1989-12-05
SE460198B (en) 1989-09-18
ES511039A0 (en) 1983-06-01
NO811346L (en) 1981-10-23
CA1198105A (en) 1985-12-17
CH650514A5 (en) 1985-07-31
NO150515B (en) 1984-07-23
FI70227C (en) 1986-09-15
GB2144409B (en) 1985-09-11
SE8700914L (en) 1987-03-04
MX9203630A (en) 1992-09-01
JPS56166117A (en) 1981-12-21
NL8101984A (en) 1981-11-16
FI811249L (en) 1981-10-23
DK159453B (en) 1990-10-15
JPH0246599B2 (en) 1990-10-16
GB2144038A (en) 1985-02-27
GB2074446B (en) 1985-04-11
SE8102489L (en) 1981-10-23
ES501539A0 (en) 1982-08-16
NL192111C (en) 1997-02-04
DE3116067A1 (en) 1982-03-11
DE3116067C2 (en) 1992-12-17
DK159453C (en) 1991-03-18
ES8206551A1 (en) 1982-08-16
FI70227B (en) 1986-02-28
LU83307A1 (en) 1981-07-24
IT1193529B (en) 1988-07-08
GB8321947D0 (en) 1983-09-14
FR2491761B1 (en) 1984-01-06
SE464635B (en) 1991-05-27
NL192111B (en) 1996-10-01
JPH0249288B2 (en) 1990-10-29
FR2491761A1 (en) 1982-04-16
CH645544A5 (en) 1984-10-15
IT8021550A0 (en) 1980-04-22
BE888472A (en) 1981-08-17
GB2074446A (en) 1981-11-04
AR231144A1 (en) 1984-09-28
SE8700914D0 (en) 1987-03-04
ES8306378A1 (en) 1983-06-01
SE8700913D0 (en) 1987-03-04

Similar Documents

Publication Publication Date Title
Fox et al. Pyrimidine nucleosides. I. A new route for the synthesis of thymine nucleosides1
HU193893B (en) Process for preparing antiviral 2-deoxy-2,2-difluoropentozyl nucleoside derivatives
GB2144409A (en) Preparation of 5'-deoxy-5'-methylthioadenosine
JPS5877881A (en) Antiviral compound
HU203363B (en) Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same as active ingredient
AU2010233367A1 (en) 6"-sialyllactose salts and process for their synthesis and for the synthesis of other a-sialyloligosaccharides
COXON et al. Simplified preparation of sophorose (2-O-β-d-glucopyranosyl-d-glucose)
US4373097A (en) Process for preparing adenosine derivatives of anti-inflammatory and analgesic activity
EP0184248A2 (en) Salts of 5'-methylthio-5'-deoxyadenosine with long-alkyl chain sulphonic acids
HU199502B (en) Process for producing new purine derivatives and pharmaceutical compositions comprising same
JPH05247078A (en) Sugar compound, sialic acid-containing sugar chain biosyhnthesis inhibitor, its production, and new intermediate
Wolfrom et al. Synthesis of 2-Amino-2-deoxy-L-arabinose (L-Arabinosamine)
US4873223A (en) Zinc salt of fructose-1,6-diphosphate
US4374831A (en) Modulators of the complement system comprising bis-glucopyranosyl arylene sulfate derivatives
GR3002313T3 (en) Compositions for therapeutical use containing organo-silico-compounds
CA2110707A1 (en) Immunosuppressive and tolerogenic oligosaccharide modified lewis x and lewis a compounds
EP0330625A3 (en) Total synthesis method for making an indole structure derivative product class, of the triptamine type, in particular, melatonin or N-acetyl-5-methoxytriptamine type, having a high purity degree and easily soluble, for therapeutic use against acquired immuno-deficiency syndromes
Leclercq et al. Synthesis and Biological Activity of a Fluoroketonucleoside: 7-(3-Deoxy-3-fluoro-β-d-glycero-hex-2-enopyranosyl-4-ulose) theophylline
JPS57102889A (en) 2'-(r)-substituted-2'-deoxyneplanocin a derivative
US3642771A (en) 5-benzyl - (2'-desoxyribosyl) uracil compounds compositions containing same and process of making and using same
WO1980000444A1 (en) Hydroxamic acid derivatives
FI68629B (en) FOERFARANDE FOER FRAMSTAELLNING AV 5'-DEOXY-5'-METHYLTIOADENOSIN
US3522237A (en) Method for the preparation of o - substituted - 6 - azacytidines and 6-azacytidine
JPS62148476A (en) Thiadiazole antiviral
PT98167A (en) PROCESS FOR THE PREPARATION OF PYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19970422